| GPRO 1.23 40.38% | PCG 14.06 5.95% | LIDR 1.47 27.83% | NVDA 217.44 -1.51% | HKPD 0.1815 -45.54% | TSLL 9.33 -6.42% | NVD 4.05 3.05% | RITR 0.0882 -4.13% | NIO 4.055 -4.14% | FLYE 2.2 61.76% | INTC 88.97 -0.60% | ONDS 7.04 -8.05% | NU 14.46 -0.62% | BITO 10.38 -2.35% | RZLV 2.39 -17.30% | PATH 18.14 -2.84% | SOXL 105.91 -6.10% | AAL 12.95 -3.57% | NOK 9.93 -2.07% | TQQQ 69.15 -3.85% | SPCX 142.23 -1.02% | AAPL 325.13 2.61% | IBIT 43.76 -2.04% | F 13.83 -0.79% | HYG 79.1 -0.89% | SQQQ 39.97 3.79% | PLUG 2.09 -3.24% | SOXS 52.22 6.53% | BIAF 6.59 44.52% | SGOV 100.41 -0.28% | BTG 5.2 -5.11% | CDE 20.2 -2.79% | QID 14.59 2.53% | SOFI 17.05 -4.64% | PFE 28.55 0.32% | SPY 761.78 -0.69% | BMNR 23.37 -7.70% | GRAB 3.46 -2.26% | AIM 0.236 4.42% | RIG 5.92 1.89% | TSLA 356.09 -3.22% | FRVO 19.75 28.41% | LQD 105.22 -0.93% | QQQ 707.64 -1.27% | SSM 4.755 77.43% | IREN 36.82 -0.79% | ETHA 18.23 -2.62% | XLE 64.77 1.27% | T 26.015 0.48% | EWZ 36.57 1.50%

Taylor Morrison Home Corporation (NYSE: TMHC) Surpasses Earnings and Revenue Estimates

Taylor Morrison Home Corporation (NYSE:TMHC) is a leading national land developer and homebuilder, known for its strategic management of inventory, pricing, and sales pace across its communities. Operating in the Zacks Building Products - Home Builders industry, TMHC has consistently outperformed revenue estimates over the past four quarters.

On October 22, 2025, TMHC reported earnings per share (EPS) of $2.01, surpassing the estimated $1.93. This achievement highlights the company's ability to exceed Wall Street expectations. Despite a year-over-year decline in EPS from $2.37, TMHC still delivered a positive surprise of 9.33%, as highlighted by Zacks.

TMHC's revenue for the third quarter of 2025 was $2.1 billion, slightly lower than the previous year's $2.12 billion. However, this figure exceeded the Zacks Consensus Estimate of $2.04 billion, resulting in a positive surprise of 2.76%. This performance underscores the company's resilience in challenging market conditions.

The company's financial health is further supported by a price-to-earnings (P/E) ratio of approximately 6.86, indicating a relatively low valuation compared to its earnings. TMHC's price-to-sales ratio of about 0.73 suggests the market values the company at less than its annual sales, while the enterprise value to sales ratio is approximately 0.97.

TMHC maintains a strong current ratio of approximately 9.43, reflecting its robust ability to cover short-term liabilities with short-term assets. The debt-to-equity ratio of about 0.36 shows a moderate level of debt compared to equity, indicating a balanced financial structure.

Published on: October 22, 2025